News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
571,780 Results
Type
Article (41368)
Company Profile (86)
Press Release (530318)
Multimedia
Podcasts (77)
Webinars (18)
Section
Business (153093)
Career Advice (2473)
Deals (28073)
Drug Delivery (117)
Drug Development (73286)
Employer Resources (142)
FDA (13920)
Job Trends (12302)
News (273626)
Policy (27330)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2566)
Academic (1)
Accelerated approval (37)
Adcomms (31)
Allergies (149)
Alliances (38609)
ALS (188)
Alzheimer's disease (1734)
Antibody-drug conjugate (ADC) (341)
Approvals (14178)
Artificial intelligence (532)
Autoimmune disease (193)
Automation (42)
Bankruptcy (312)
Best Places to Work (9970)
BIOSECURE Act (16)
Biosimilars (176)
Biotechnology (63)
Bladder cancer (171)
Brain cancer (60)
Breast cancer (644)
Cancer (4959)
Cardiovascular disease (431)
Career advice (2098)
Career pathing (39)
CAR-T (271)
CDC (54)
Cell therapy (734)
Cervical cancer (32)
Clinical research (63404)
Collaboration (1595)
Company closure (4)
Compensation (644)
Complete response letters (76)
COVID-19 (2598)
CRISPR (91)
C-suite (973)
Cystic fibrosis (123)
Data (6599)
Decentralized trials (2)
Denatured (13)
Depression (158)
Diabetes (516)
Diagnostics (6166)
Digital health (42)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (245)
Drug pricing (181)
Drug shortages (26)
Duchenne muscular dystrophy (262)
Earnings (59074)
Editorial (59)
Employer branding (19)
Employer resources (134)
Events (80971)
Executive appointments (1028)
FDA (17006)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (26)
Funding (1371)
Gene editing (195)
Generative AI (50)
Gene therapy (644)
GLP-1 (986)
Government (4408)
Grass and pollen (7)
Guidances (387)
Healthcare (16174)
HIV (70)
Huntington's disease (52)
IgA nephropathy (87)
Immunology and inflammation (278)
Immuno-oncology (76)
Indications (139)
Infectious disease (2893)
Inflammatory bowel disease (190)
Inflation Reduction Act (13)
Influenza (118)
Intellectual property (249)
Interviews (532)
IPO (12809)
IRA (50)
Job creations (2614)
Job search strategy (1689)
JPM (56)
Kidney cancer (20)
Labor market (64)
Layoffs (509)
Leadership (39)
Legal (5833)
Liver cancer (91)
Longevity (22)
Lung cancer (696)
Lymphoma (383)
Machine learning (41)
Management (51)
Manufacturing (749)
MASH (190)
Medical device (11074)
Medtech (11138)
Mergers & acquisitions (16276)
Metabolic disorders (1349)
mRNA (154)
Multiple sclerosis (166)
NASH (24)
Neurodegenerative disease (366)
Neuropsychiatric disorders (101)
Neuroscience (3071)
Neurotech (1)
NextGen: Class of 2026 (5533)
Non-profit (4033)
Now hiring (61)
Obesity (625)
Opinion (288)
Ovarian cancer (168)
Pain (208)
Pancreatic cancer (241)
Parkinson's disease (319)
Partnered (29)
Patents (506)
Patient recruitment (545)
Peanut (53)
People (52574)
Pharmaceutical (19)
Pharmacy benefit managers (19)
Phase 1 (19506)
Phase 2 (27861)
Phase 3 (21270)
Pipeline (6300)
Policy (291)
Postmarket research (2316)
Preclinical (7990)
Press Release (61)
Prostate cancer (257)
Psychedelics (56)
Radiopharmaceuticals (258)
Rare diseases (937)
Real estate (4165)
Recruiting (60)
Regulatory (21587)
Reports (31)
Research institute (2184)
Resumes & cover letters (361)
Rett syndrome (31)
RNA editing (15)
RSV (76)
Schizophrenia (161)
Series A (236)
Series B (170)
Service/supplier (3)
Sickle cell disease (101)
Special edition (19)
Spinal muscular atrophy (159)
Sponsored (40)
Startups (2796)
State (2)
Stomach cancer (19)
Supply chain (99)
Tariffs (76)
The Weekly (62)
Vaccines (973)
Venture capital (90)
Weight loss (413)
Women's health (86)
Worklife (19)
Date
Today (116)
Last 7 days (574)
Last 30 days (2631)
Last 365 days (26577)
2026 (6067)
2025 (26698)
2024 (30698)
2023 (34519)
2022 (45065)
2021 (48409)
2020 (46745)
2019 (39825)
2018 (30158)
2017 (27060)
2016 (25768)
2015 (30118)
2014 (22591)
2013 (18334)
2012 (19592)
2011 (20620)
2010 (18223)
Location
Africa (740)
Alabama (81)
Alaska (5)
Arizona (222)
Arkansas (11)
Asia (35575)
Australia (7316)
California (10075)
Canada (3127)
China (1107)
Colorado (426)
Connecticut (407)
Delaware (331)
Europe (79132)
Florida (1640)
Georgia (322)
Hawaii (1)
Idaho (53)
Illinois (798)
India (68)
Indiana (479)
Iowa (18)
Japan (437)
Kansas (113)
Kentucky (33)
Louisiana (34)
Maine (60)
Maryland (1306)
Massachusetts (6899)
Michigan (298)
Minnesota (513)
Mississippi (5)
Missouri (124)
Montana (25)
Nebraska (25)
Nevada (118)
New Hampshire (77)
New Jersey (2889)
New Mexico (21)
New York (2693)
North Carolina (1249)
North Dakota (6)
Northern California (4901)
Ohio (291)
Oklahoma (11)
Oregon (30)
Pennsylvania (2041)
Puerto Rico (23)
Rhode Island (39)
South America (1007)
South Carolina (67)
South Dakota (1)
Southern California (4052)
Tennessee (160)
Texas (1675)
United States (35909)
Utah (335)
Vermont (1)
Virginia (250)
Washington D.C. (65)
Washington State (820)
West Virginia (4)
Wisconsin (91)
Wyoming (2)
571,780 Results for "reshape lifesciences formally known as enteromedics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics
August 8, 2025
·
3 min read
Opinion
2025 Reshaped the FDA. What Will 2026 Hold?
The FDA underwent significant changes during the first year of the second Trump administration, directly affecting business risk and opportunity. Understanding key 2025 trends will be critical to developing regulatory strategies and maximizing opportunities for success.
February 9, 2026
·
6 min read
·
Claire Davies
Press Releases
Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care
March 19, 2026
·
11 min read
Press Releases
Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as HIND
August 14, 2025
·
3 min read
Press Releases
Greenwich LifeSciences Provides Update on Upcoming AACR Meeting
March 18, 2026
·
11 min read
Press Releases
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
March 19, 2026
·
10 min read
Opinion
Ongoing Regulatory Uncertainty Means Innovation Is Now Higher Risk
Regulatory uncertainty is no longer background noise. It is a material investment risk that reshapes how capital is deployed and pipelines are prioritized.
February 18, 2026
·
6 min read
·
Harris Kaplan
IN PARTNERSHIP WITH ELEMENT
How Supply Chain Turbulence Is Reshaping Biotech Strategy
In this episode presented by Element Materials Technology, guests Dr. Jihye Jang-Lee and Dr. Khanh Courtney discuss how small biotechs face mounting pressure amid manufacturing uncertainties.
October 23, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Integra LifeSciences Announces Key Executive Leadership Appointments
February 17, 2026
·
5 min read
Press Releases
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01
March 16, 2026
·
8 min read
1 of 57,178
Next
